Ecolab (ECL) FY2025 results: revenue $16.1 billion, up 2.2% on the year
Ecolab Inc. (ECL) reported revenue of $16.1 billion for fiscal 2025, the year ended 31 December 2025, up 2.2% on the year before. Net income was $2.1 billion, down 1.7%, and diluted earnings per share $7.28. The figures are the company's own, from the 10-K it filed with the SEC on 23 February 2026.
this yearthe year beforeHover a bar for its figure.
The year in brief
What management said about the year
Guidance figures: 3 new, 1 kept.
- Reported net sales reached $16.1 billion: Reported GAAP net sales for the year ended December 31, 2025 were $16,081.2 million, against $15,741.4 million in 2024. At 2026 fixed rates the subtotal was $16,298.4 million, against $15,998.8 million.
- Reported operating income declined: Reported GAAP operating income was $2,737.6 million in 2025, against $2,802.4 million in 2024.
- Global Water sales and profit rose: Global Water net sales were $8,107.7 million at 2026 fixed rates, against $7,903.8 million. Its operating income was $1,357.5 million, against $1,296.9 million.
- Special charge replaced prior-year gain: Special (gains) and charges were a $150.3 million charge in 2025, against a $188.7 million gain in 2024.
- About $4.75 billion cash at closing: Ecolab agreed to buy CoolIT from funds managed by KKR, paying approximately $4.75 billion in cash at closing, subject to customary adjustments.
From this 10-K
Ecolab sells water treatment, cleaning, sanitising and infection prevention products and the services that go with them, largely to businesses that have to keep processes clean and water usable. It was incorporated in Delaware in 1924. The company reports $16 billion of annual sales, 48,000 associates, and customers in more than 170 countries and 40 industries, and states that it helps protect one-third of the world's food production and a quarter of the power generated. It operates directly in approximately 100 countries outside the United States, through wholly owned subsidiaries or in some cases a joint venture with a local partner, with selected products exported to distributors, agents or licensees elsewhere.
The four quarters: Q1 FY2025 · Q2 FY2025 · Q3 FY2025 · Q4 FY2025
Income statement (profit and loss)
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Revenue | 16,081 | 15,741 | 15,320 | +2.2% | |
| Cost of revenue | 8,931 | 8,900 | 9,155 | +0.3% | |
| Gross profit | 7,150 | 6,842 | 6,165 | +4.5% | |
| Gross margin | 44.5% | 43.5% | 40.2% | ||
| Research and development | 202 | 207 | 192 | -2.4% | |
| Selling, general and administrative | 4,258 | 4,228 | 4,062 | +0.7% | |
| Operating income | 2,738 | 2,802 | 1,992 | -2.3% | |
| Operating margin | 17.0% | 17.8% | 13.0% | ||
| Interest expense | 306 | 340 | 349 | -10.0% | |
| Pre-tax income | 2,548 | 2,571 | 1,756 | -0.9% | |
| Income tax | 455 | 439 | 362 | +3.5% | |
| Effective tax rate | 17.8% | 17.1% | 20.6% | ||
| Net income | 2,076 | 2,112 | 1,372 | -1.7% | |
| Net margin | 12.9% | 13.4% | 9.0% | ||
| Diluted EPS | $7.28 | $7.37 | $4.79 | -1.2% |
Read more
Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.Cash flow
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Operating cash flow | 2,953 | 2,814 | 2,412 | +4.9% | |
| Capital expenditure | 1,048 | 994 | 775 | +5.4% | |
| Free cash flow | 1,904 | 1,819 | 1,637 | +4.7% | |
| Free cash flow margin | 11.8% | 11.6% | 10.7% | ||
| Cash from investing | -2,707 | -434 | -990 | ||
| Cash from financing | -853 | -2,024 | -1,055 | ||
| Depreciation and amortisation | 977 | 936 | 924 | +4.3% | |
| Share-based compensation | 137 | 135 | 95.1 | +1.3% | |
| Buybacks | 784 | 986 | 13.7 | -20.5% | |
| Dividends paid | 754 | 664 | 617 | +13.4% | |
| Dividend per share | $2.68 | $2.36 | $2.16 | +13.6% | |
| Diluted shares, weighted | 285m | 287m | 286m | -0.5% | |
| Shares outstanding at period end | 282m | 283m | 285m | -0.5% |
Balance sheet
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Shareholders' equity | 9,771 | 8,757 | 8,045 | +11.6% | |
| Non-controlling interest | 33.7 | 31.9 | 27.5 | +5.6% | |
| Debt | 8,236 | 7,565 | 8,182 | +8.9% | |
| Other liabilities | 6,656 | 6,034 | 5,593 | +10.3% | |
| Total liabilities and equity | 24,696 | 22,388 | 21,847 | +10.3% | |
| Fixed assets | 4,277 | 3,752 | 3,475 | +14.0% | |
| Goodwill | 9,227 | 7,907 | 8,148 | +16.7% | |
| Intangible assets | 3,688 | 3,309 | 3,494 | +11.5% | |
| Cash and equivalents | 646 | 1,257 | 920 | -48.6% | |
| Receivables | 3,249 | 2,865 | 2,834 | +13.4% | |
| Inventory | 1,490 | 1,465 | 1,497 | +1.7% | |
| Other assets | 2,118 | 1,833 | 1,479 | +15.6% | |
| Total assets | 24,696 | 22,388 | 21,847 | +10.3% |
10-K for the year ended 31 December 2025, filed 23 February 2026: the filing.